Search Results for: "Other News to Note"
-
Pharma: Other News To Note
The FDA assigned a PDUFA date of March 27, 2013BioWorld Today | Wednesday, December 12, 2012 -
Pharma: Other News To Note
The FDA assigned a PDUFA date of March 27, 2013BioWorld Today | Monday, December 3, 2012 -
Other News To Note
The NDA has a PDUFA date of July 28, 2013, and its acceptance triggered a $15 million milestone payment to AVEOBioWorld Today | Thursday, November 29, 2012 -
Other News To Note
The agency classified the resubmission as a complete, Class 2 response to its March 26, action letter and set a PDUFA date of April 15, 2013BioWorld Today | Tuesday, November 27, 2012 -
Other News To Note
In other news, Orexo said the FDA accepted for review its new drug application for Zubsolv, a sublingual formulation of buprenorphine and naloxone, and set a PDUFA date of July l6, 2013BioWorld International | Wednesday, November 21, 2012 -
Other News To Note
Orexo AB, of Uppsala, Sweden, said the FDA accepted for review its new drug application for Zubsolv, a sublingual formulation of buprenorphine and naloxone, and set a PDUFA date of July l6, 2013BioWorld Today | Tuesday, November 20, 2012 -
Other News To Note
10 action letter and has set a PDUFA date of April 30, 2013BioWorld Today | Thursday, November 15, 2012 -
Other News To Note
Heplisav has a PDUFA date of Feb. 24, 2013BioWorld Today | Wednesday, November 14, 2012 -
Other News To Note
The PDUFA date is Feb. 26, 2013BioWorld Today | Thursday, November 8, 2012 -
Other News To Note
The PDUFA date for raxibacumab is Dec. 15BioWorld International | Wednesday, November 7, 2012 -
Other News To Note
Ventrus has started to enroll in its second Phase III pivotal trial, with results expected early fourth quarter 2013, and assuming a successful outcome, expects to file an NDA late in the fourth quarter of 2013 with an anticipated PDUFA date at the end of 2014BioWorld Today | Tuesday, November 6, 2012 -
Other News To Note
The PDUFA date for raxibacumab is Dec. 15BioWorld Today | Monday, November 5, 2012 -
Other News To Note
The FDA also granted Ariad's request for priority, accelerated review, and set a PDUFA date of March 27, 2013BioWorld Today | Thursday, October 25, 2012 -
Other News To Note
The compound is an RNA nucleic acid, and bears a PDUFA date of Feb. 2, 2013BioWorld Today | Tuesday, October 23, 2012 -
Other News To Note
Biogen Idec Inc., of Weston, Mass., said the FDA extended the initial PDUFA date for its review of the new drug application for BG-12 (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis, by three monthsBioWorld Today | Friday, October 19, 2012 -
Other News To Note
The PDUFA date is Feb. 5, 2013BioWorld Today | Wednesday, October 17, 2012 -
Pharma: Other News To Note
A PDUFA date has been set for March 27, 2013BioWorld Today | Wednesday, October 17, 2012 -
Other News To Note
The NDA will be subject to a standard review and will have a PDUFA date of May 31, 2013BioWorld Today | Tuesday, October 16, 2012 -
Other News To Note
The agency told the company the review of the new drug application for pomalidomide is continuing, with the previously disclosed PDUFA date of Feb. 10, 2013BioWorld Today | Thursday, October 4, 2012 -
Pharma: Other News To Note
The new PDUFA date is March 17, 2013BioWorld Today | Friday, September 28, 2012
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.